News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,835 Results
Type
Article (47176)
Company Profile (295)
Press Release (688363)
Multimedia
Podcasts (64)
Webinars (14)
Section
Business (210734)
Career Advice (2380)
Deals (37290)
Drug Delivery (109)
Drug Development (83594)
Employer Resources (183)
FDA (16702)
Job Trends (15603)
News (357672)
Policy (34175)
Tag
Academia (2800)
Accelerated approval (5)
Adcomms (24)
Allergies (91)
Alliances (51395)
ALS (107)
Alzheimer's disease (1444)
Antibody-drug conjugate (ADC) (163)
Approvals (16684)
Artificial intelligence (324)
Autoimmune disease (29)
Automation (18)
Bankruptcy (373)
Best Places to Work (12102)
BIOSECURE Act (19)
Biosimilars (114)
Biotechnology (203)
Bladder cancer (90)
Brain cancer (36)
Breast cancer (355)
Cancer (2741)
Cardiovascular disease (210)
Career advice (1996)
Career pathing (34)
CAR-T (187)
CDC (30)
Cell therapy (501)
Cervical cancer (21)
Clinical research (68355)
Collaboration (975)
Company closure (3)
Compensation (629)
Complete response letters (22)
COVID-19 (2722)
CRISPR (57)
C-suite (302)
Cystic fibrosis (111)
Data (2797)
Decentralized trials (2)
Denatured (21)
Depression (57)
Diabetes (308)
Diagnostics (6634)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (47)
Drug discovery (149)
Drug pricing (130)
Drug shortages (29)
Duchenne muscular dystrophy (117)
Earnings (88789)
Editorial (43)
Employer branding (23)
Employer resources (159)
Events (118718)
Executive appointments (843)
FDA (18243)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (879)
Gene editing (131)
Generative AI (26)
Gene therapy (375)
GLP-1 (798)
Government (4757)
Grass and pollen (4)
Guidances (179)
Healthcare (19959)
Huntington's disease (27)
IgA nephropathy (36)
Immunology and inflammation (144)
Immuno-oncology (6)
Indications (35)
Infectious disease (2882)
Inflammatory bowel disease (154)
Inflation Reduction Act (9)
Influenza (60)
Intellectual property (111)
Interviews (400)
IPO (16958)
IRA (43)
Job creations (3908)
Job search strategy (1684)
Kidney cancer (14)
Labor market (49)
Layoffs (518)
Leadership (22)
Legal (8326)
Liver cancer (77)
Lung cancer (387)
Lymphoma (191)
Machine learning (9)
Management (63)
Manufacturing (373)
MASH (85)
Medical device (13885)
Medtech (13890)
Mergers & acquisitions (21010)
Metabolic disorders (796)
Multiple sclerosis (95)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (31)
Neuroscience (2103)
NextGen: Class of 2025 (7048)
Non-profit (4931)
Now hiring (45)
Obesity (413)
Opinion (247)
Ovarian cancer (94)
Pain (101)
Pancreatic cancer (104)
Parkinson's disease (179)
Partnered (22)
Patents (278)
Patient recruitment (136)
Peanut (49)
People (59803)
Pharmaceutical (77)
Pharmacy benefit managers (22)
Phase I (21302)
Phase II (30049)
Phase III (22418)
Pipeline (1556)
Policy (184)
Postmarket research (2741)
Preclinical (9172)
Press Release (68)
Prostate cancer (134)
Psychedelics (31)
Radiopharmaceuticals (268)
Rare diseases (451)
Real estate (6244)
Recruiting (69)
Regulatory (23453)
Reports (53)
Research institute (2512)
Resumes & cover letters (391)
Rett syndrome (9)
RNA editing (8)
RSV (47)
Schizophrenia (84)
Series A (151)
Series B (102)
Service/supplier (12)
Sickle cell disease (62)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3770)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (56)
The Weekly (41)
Vaccines (773)
Venture capitalists (48)
Weight loss (265)
Women's health (41)
Worklife (19)
Date
Last 7 days (503)
Last 30 days (2388)
Last 365 days (32912)
2025 (15548)
2024 (36375)
2023 (41090)
2022 (52360)
2021 (57083)
2020 (55904)
2019 (49071)
2018 (37070)
2017 (33532)
2016 (33182)
2015 (39305)
2014 (32937)
2013 (28061)
2012 (30272)
2011 (30912)
2010 (29118)
Location
Africa (821)
Alabama (58)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (40419)
Australia (6704)
California (7169)
Canada (2257)
China (645)
Colorado (303)
Connecticut (310)
Delaware (177)
Europe (89151)
Florida (1071)
Georgia (242)
Hawaii (1)
Idaho (61)
Illinois (637)
India (28)
Indiana (352)
Iowa (15)
Japan (212)
Kansas (111)
Kentucky (28)
Louisiana (15)
Maine (64)
Maryland (1003)
Massachusetts (5405)
Michigan (244)
Minnesota (440)
Mississippi (3)
Missouri (89)
Montana (32)
Nebraska (25)
Nevada (77)
New Hampshire (69)
New Jersey (2012)
New Mexico (30)
New York (2022)
North Carolina (1091)
North Dakota (10)
Northern California (3148)
Ohio (232)
Oklahoma (15)
Oregon (35)
Pennsylvania (1556)
Puerto Rico (17)
Rhode Island (37)
South America (1226)
South Carolina (34)
South Dakota (1)
Southern California (2677)
Tennessee (121)
Texas (1066)
United States (26803)
Utah (214)
Virginia (175)
Washington D.C. (75)
Washington State (623)
West Virginia (4)
Wisconsin (65)
735,835 Results for "neogenomics inc acquired by american communications enterprises inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bexion Pharmaceuticals, Inc. Announces Acceptance of Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 29, 2025
·
2 min read
Press Releases
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
May 28, 2025
·
5 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
NeoGenomics to Participate in Upcoming June Investor Conferences
May 20, 2025
·
1 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
NeoGenomics Reports First Quarter 2025 Results
April 29, 2025
·
19 min read
Press Releases
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
May 22, 2025
·
9 min read
Press Releases
NeoGenomics Completes Acquisition of Pathline
April 7, 2025
·
1 min read
1 of 73,584
Next
